The Hindu Business Line : AstraZeneca clears stock split

AstraZeneca Pharma India Ltd has informed the BSE that its board on Tuesday approved a 1:5 stock split. The company seeks to split its shares of Rs 10 each into five shares of Rs 2 each. It has called an EGM on June 6 for final approval. Post-split, the authorised capital of Rs 5 crore, as per the Memorandum and Articles of Association, would stand divided into 2.5 crore equity shares of the face value of Rs 2 each.

More Stories on : Announcements | Stocks | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
GAIL makes first global LNG purchase

AstraZeneca clears stock split

Cubex bags order from NTPC

BOC India's Q4 net up 66 pc

Federal Mogul makes fresh bid to increase stake in Goetze

Ashapura Volclay doubles Bhuj plant capacity

`Many cos keen to set up units in Mangalore SEZ'

CCEA nod for HNL expansion

Will shut Mumbai operations in 2-3 years: B.K. Birla

FACT hands over 50 acres for waste treatment plant

Indage Group plans to enter food segment

IOC plans to expand export market in lubricants

Problems galore for ONGC at Bengal offshore

BPL Group sees energetic growth for healthcare biz

Ashok Leyland sales up in April

30 pc rise in Keltron turnover